MERIDIAN, Miss., Sept. 11, 2016 -- Opternative, a “vision test” app, entered the market without the necessary approval to guarantee its use as a safe and effective tool to diagnose vision problems, reports Primary Eyecare and Optical of Meridian. The American Optometric Association has recently filed a complaint against the marketing and use of Opternative. Patients who want to maintain their eye health should continue the practice of annual in-person eye exams.
The American Optometric Association (AOA) has lodged an FDA complaint against Opternative. Without any FDA review of the “vision test” app from Opternative, there may be significant health risks to the general public. The complaint was submitted as of April 4th with the argument that marketing of Opternative without the support of federal approval violates the Food, Drug and Cosmetic Act (FDCA). Inventors filed a patent application but the product has not received needed premarket approval before being marketed to the public. The AOA requests that the device be properly reviewed by the FDA before potentially reentering the market. Eye doctors are worried about the potential negative impact of unproven products that can place patients at risk.
Dr. Steven A. Loomis, O.D., AOA president stated:
“Instead of apps or device of the moment that promise everything but deliver inadequate or incomplete information, Americans want new health care technologies, like those incorporated into my practice and optometry practices across the country, that strengthen the doctor-patient relationship and help make people healthier. In this era of rapid health care change, our AOA and state associations are on the leading edge of the fight for very basic health and safety standards, and a future in which health care efficiency is based on gains in quality and improved patient outcomes.”
Dr. Minh Duong, an optometrist at Primary Eyecare and Optical of Meridian says that, “My team and I support the initiative of the AOA and warn our patients of using Opternative, an unproven technology that could potentially cause risks to users. This “vision app” technology requires individuals to competently use a number of self-administered tests that in some instances do not follow customary vision practices. Patients should see their eye doctor for accurate vision exams using proven, approved and standardized technologies to maintain their vision and identify any problems.”
Dr. Minh Duong offers vision services at Primary Eyecare and Optical of Meridian to the residents of Meridian and the surrounding communities in Mississippi and Alabama. This family practice helps children and adults with eye care and vision needs. Services include eye exams, Optomap retinal imaging, eye disease care, vision testing, contact lens exams, and pre-operative and post-operative care.
Call (601) 485-2020 to learn about in-person vision exams or visit http://primaryeyecarems.com/ for more details on their optometry services.
Primary Eyecare and Optical of Meridian, (601) 485-2020


Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 



